TAM
Tocqueville Asset Management’s Axsome Therapeutics AXSM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $543K | Hold |
5,200
| – | – | 0.01% | 409 |
|
|
2025
Q1 | $606K | Buy |
5,200
+250
| +5% | +$29.2K | 0.01% | 388 |
|
|
2024
Q4 | $419K | Sell |
4,950
-150
| -3% | -$12.7K | 0.01% | 439 |
|
|
2024
Q3 | $458K | Sell |
5,100
-100
| -2% | -$8.99K | 0.01% | 414 |
|
|
2024
Q2 | $419K | Sell |
5,200
-1,100
| -17% | -$88.6K | 0.01% | 422 |
|
|
2024
Q1 | $503K | Sell |
6,300
-400
| -6% | -$31.9K | 0.01% | 408 |
|
|
2023
Q4 | $533K | Buy |
6,700
+500
| +8% | +$39.8K | 0.01% | 389 |
|
|
2023
Q3 | $433K | Sell |
6,200
-1,000
| -14% | -$69.9K | 0.01% | 414 |
|
|
2023
Q2 | $517K | Hold |
7,200
| – | – | 0.01% | 410 |
|
|
2023
Q1 | $444K | Hold |
7,200
| – | – | 0.01% | 421 |
|
|
2022
Q4 | $555K | Buy |
7,200
+100
| +1% | +$7.71K | 0.01% | 430 |
|
|
2022
Q3 | $317K | Buy |
+7,100
| New | +$317K | 0.01% | 507 |
|
|
2020
Q3 | – | Sell |
-2,500
| Closed | -$206K | – | 651 |
|
|
2020
Q2 | $206K | Buy |
+2,500
| New | +$206K | ﹤0.01% | 622 |
|